ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 44 filers reported holding ATYR PHARMA INC in Q1 2022. The put-call ratio across all filers is 3.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,060 | -50.5% | 78,519 | -32.3% | 0.00% | – |
| Q2 2023 | $250,407 | +68.9% | 115,929 | +64.2% | 0.00% | – |
| Q1 2023 | $148,271 | +47.6% | 70,605 | +53.9% | 0.00% | – |
| Q4 2022 | $100,457 | -27.2% | 45,871 | 0.0% | 0.00% | – |
| Q3 2022 | $138,000 | +6.2% | 45,871 | 0.0% | 0.00% | – |
| Q2 2022 | $130,000 | -45.4% | 45,871 | +3.3% | 0.00% | – |
| Q1 2022 | $238,000 | -28.3% | 44,406 | 0.0% | 0.00% | – |
| Q4 2021 | $332,000 | +48.2% | 44,406 | +80.0% | 0.00% | – |
| Q3 2021 | $224,000 | +76.4% | 24,673 | -5.5% | 0.00% | – |
| Q2 2021 | $127,000 | +29.6% | 26,105 | +18.5% | 0.00% | – |
| Q1 2021 | $98,000 | +15.3% | 22,033 | +0.4% | 0.00% | – |
| Q4 2020 | $85,000 | +26.9% | 21,946 | +6.2% | 0.00% | – |
| Q3 2020 | $67,000 | -27.2% | 20,658 | 0.0% | 0.00% | – |
| Q2 2020 | $92,000 | – | 20,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,626,624 | $7,310,066 | 2.43% |
| Tikvah Management LLC | 2,460,833 | $3,888,116 | 1.40% |
| TANG CAPITAL MANAGEMENT LLC | 471,134 | $744,392 | 0.10% |
| FEDERATED HERMES, INC. | 10,169,600 | $16,067,968 | 0.04% |
| Alyeska Investment Group, L.P. | 2,455,555 | $3,879,777 | 0.03% |
| XTX Topco Ltd | 73,894 | $116,753 | 0.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 10,000 | $15,800 | 0.02% |
| Pale Fire Capital SE | 55,857 | $88,254 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,559 | $44 | 0.00% |
| Virtu Financial LLC | 13,662 | $22 | 0.00% |